News

BigBear.ai Holdings, Inc. BBAI is increasingly positioning itself at the intersection of AI, border security and global trade modernization. The key question for investors is whether its expanding

The FTSE 100 kicked off 2026 on a strong note, building steady upward momentum. U.K.’s benchmark index has risen 7.69% so far this year and 22.75% over the past year, outperforming its transatlantic

Ironwood Pharmaceuticals IRWD and Bausch Health BHC operate in the branded gastrointestinal (GI) drug market, with a focus on treatments for irritable bowel syndrome (IBS) and other therapeutic

Shares of Elite Pharmaceuticals, Inc. ELTP have lost 10.7% since the company reported its earnings for the quarter ended Dec. 31, 2025. This compares with the S&P 500 Index’s 0.2% gain over the same

The renowned health and wellness platform, Hims & Hers Health, Inc. HIMS, has positioned itself as a leading digital health and wellness platform built around expanding access to personalized

Economic indexes had been on a roll lately, putting up better-than-expected figures on growth, productivity, employment and so on. That appears to have come to an end this morning with a slew of

Opendoor Technologies Inc. OPEN reported fourth-quarter 2025 results, with adjusted earnings and revenues surpassing the Zacks Consensus Estimate. On a year-over-year basis, the top line decreased

An updated edition of the Jan. 6, 2026, article.

Genomics is the comprehensive study of genomes—the complete set of deoxyribonucleic acid (DNA) within an organism. Rapid scientific progress in this

Pfizer PFE and AstraZeneca AZN are two global pharmaceutical leaders with a commanding presence in oncology. For Pfizer, oncology is a key growth driver, accounting for roughly 27% of total company

An updated edition of the Dec. 18, 2025, article.The U.S. beauty and cosmetics industry remains one of the more resilient segments within the consumer products space, offering a defensive growth

In a significant strategic pivot, NVIDIA NVDA is reportedly in the final stages of negotiating a $30 billion equity investment in OpenAI, part of a blockbuster funding round that could value the

Home improvement retailer Home Depot HD is set to announce fourth-quarter earnings results before Tuesday’s opening bell. The company missed the earnings mark in three of the last four quarters. But

Extra Space Storage Inc. EXR reported fourth-quarter 2025 core funds from operations (FFO) per share of $2.08, surpassing the Zacks Consensus Estimate of $2.03. The figure increased 2.05% from the

Sonic Automotive SAH, one of the leading automotive retailers in the United States, posted fourth-quarter 2025 adjusted earnings per share of $1.52, which increased 1% year over year. Total revenues

Shares of Walmart Inc. WMT slipped 1.4% yesterday, following the company’s better-than-expected fourth-quarter fiscal 2026 results. Despite comfortably surpassing analysts’ estimates for earnings

Oklo Inc. OKLO offers long-term promise in advanced nuclear, but the near-term setup remains difficult. The stock carries a Zacks Rank #4 (Sell), signaling weak momentum over the next one to three

Oklo Inc. OKLO is not trying to win by selling reactor blueprints. The company is building a utility-like model around small nuclear plants it expects to own and operate, with revenue tied to

Friday, February 20th, 2026Economic indexes had been on a roll lately, putting up better-than-expected figures on growth, productivity, employment and so on. That appears to have come to an end this

Insmed INSM reported a fourth-quarter 2025 loss of $1.54 per share, wider than the Zacks Consensus Estimate of a loss of $1.07. In the year-ago quarter, the company had incurred a loss of $1.32.

Etsy ETSY reported fourth-quarter 2025 earnings of 92 cents per share, which beat the Zacks Consensus Estimate by 4.55% but declined 10.68% year over year.Fourth-quarter 2025 revenues increased

MercadoLibre MELI is slated to report fourth-quarter 2025 results on Feb. 24.The Zacks Consensus Estimate for fourth-quarter revenues is pegged at $8.52 billion, suggesting year-over-year growth of

LKQ Corporation LKQ delivered fourth-quarter 2025 adjusted earnings of 59 cents per share, which missed the Zacks Consensus Estimate of 65 cents and declined from 80 cents reported in the year-ago

ANI Pharmaceuticals (ANIP) is expected to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known consensus

The market expects Chart Industries (GTLS) to deliver a year-over-year increase in earnings on higher revenues when it reports results for the quarter ended December 2025. This widely-known